Gliomatosis cerebri physical examination: Difference between revisions
No edit summary |
|||
| Line 16: | Line 16: | ||
*[[Vision loss]] | *[[Vision loss]] | ||
*[[Ataxia]] | *[[Ataxia]] | ||
*[[ | *[[Altered mental status]] | ||
*[[Aphasia]] | *[[Aphasia]] | ||
*Focal neurological defects | *Focal neurological defects | ||
Revision as of 01:11, 8 October 2015
|
Gliomatosis cerebri Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Gliomatosis cerebri physical examination On the Web |
|
American Roentgen Ray Society Images of Gliomatosis cerebri physical examination |
|
Risk calculators and risk factors for Gliomatosis cerebri physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]
Overview
Common physical examination findings of gliomatosis cerebri include dysphagia, dysarthria, nystagmus, papilledema, hemiparesis, facial paresthesia, vision loss, ataxia, mental status changes, aphasia, and focal neurological defects (corticospinal tract defects, spinocerebellar tract defects, and cranioneuropathies).[1][2]
Physical Examination
Common physical examination findings of gliomatosis cerebri include:[1][2]
- Dysphagia
- Dysarthria
- Nystagmus
- Papilledema
- Hemiparesis
- Facial paresthesia
- Vision loss
- Ataxia
- Altered mental status
- Aphasia
- Focal neurological defects
References
- ↑ 1.0 1.1 Buis DR, van der Valk P, De Witt Hamer PC (2012). "Subcutaneous tumor seeding after biopsy in gliomatosis cerebri". J Neurooncol. 106 (2): 431–5. doi:10.1007/s11060-011-0678-2. PMC 3230756. PMID 21837541.
- ↑ 2.0 2.1 Rajz GG, Nass D, Talianski E, Pfeffer R, Spiegelmann R, Cohen ZR (2012). "Presentation patterns and outcome of gliomatosis cerebri". Oncol Lett. 3 (1): 209–213. doi:10.3892/ol.2011.445. PMC 3362440. PMID 22740882.